to evaluate the effect of yashtimadhu amlaki churna in hairfall and to compare the mode of administration of yashtimadhukadi tail on hairfall through scalp and through nasal route.

A Comparative Clinical Trial To Evaluate The Efficacy Of Nasya And Shiro-Abhayanga Of Yashtimadhukadi Tailam With Oral Administration Of Yashtimadhu-Amlaki Churna In Khalitya W.S.R. To Hairfall

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/04/008441

Enrollment

Registered

2017-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Khalitya (Hairfall)

Interventions

Intervention1: Shiro Abhyanga with oral administration of yashtimadhu amlaki churna.: Shiro abhyanga will be done using yashtimadhukadi tail for a period of 30 days. Yashtimadhu churna 4 gms and amlak

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients who have classical signs and symptoms of khalitya since one month or more. 2)Patients within age group of 20 to 40 years of either sex.

Exclusion criteria

Exclusion criteria: 1)Patients below 20 years and above 40 years. 2)Patients who have diseases like Alopecia totalis, Tinea capitis, folliculisis devaculans and in Ayurvediya terms patients of Arunshika, Indralupta. 3)Patient suffering from any systemic diseases.

Design outcomes

Primary

Measure	Time frame
It is expected that trial drug will exert a significant action over hairfall with other associated symptoms.Timepoint: 15 months	—

Secondary

Measure	Time frame
Significant reduction in the hairfall (through the procedure and the oral drug) will increase quality of life, self conidence and self esteem of the person with total gain of mental, physical and spiritual health.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactParul Anand

National Institute of Ayurveda

anand.parul.mailbox@gmail.com9086081993

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026